SEC Form 4 · accession 0001209191-19-003059
Karyopharm Therapeutics Inc. · KPTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sharon Shacham
Officer — President & CSO
Period of report
Jan 7, 2019
Accepted (ET)
Jan 9, 2019 · 4:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001503802
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 7, 2019 | M | 12,500 | $0.033 | A | 743,634 | D | |
| Common StockF3 | Jan 7, 2019 | S | 12,500 | $10.2259 | D | 731,134 | D | |
| Common StockF4 | holding | — | — | — | 529,767 | I | By Spouse | |
| Common StockF2,F5 | holding | — | — | — | 29,685 | I | By GRAT | |
| Common StockF4,F6 | holding | — | — | — | 29,685 | I | By Spouse's GRAT |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F7 | $0.033 | Jan 7, 2019 | M | 12,500 | D | — | Oct 21, 2020 | Common Stock | 12,500 | 15,357 | D |
Explanation of responses
- F1These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2Reflects the transfer of 17,624 shares from the Sharon Shacham 2016 Qualified Annuity Interest Trust (the "GRAT") to the reporting person on December 10, 2018.
- F3Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.45, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4Reflects the transfer of 17,624 shares from the Michael G. Kauffman 2016 Qualified Annuity Interest Trust (the "Spouse's GRAT") to the spouse of the reporting person on December 10, 2018.
- F5These shares are held by the GRAT.
- F6These shares are held by the Spouse's GRAT.
- F7This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on October 22, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter.